Resource Type: Placemat

Insights from the National Alliance 2025 high-cost claims coalition workshops, along with the latest research, highlight the urgent need for employers to embrace data-driven, collaborative, prevention-focused strategies to address cardiometabolic […]

Cancer care poses one of the most complex and costly challenges for employers, driven by rising drug prices, longer treatment durations, more younger people being diagnosed with advanced-stage cancers, and […]

Biosimilars are the future of specialty drug therapy, costing, on average, 50% less than their biological reference products, with some exceeding 90%. While adoption has been hindered by barriers such […]

Action-oriented recommendations for coalitions, employers and other plan sponsors, and healthcare and benefits professionals.

A summary of the latest National Alliance resources.

For decades the PBM industry has been plagued by misalignment, opacity, and consolidation. Rather than improving drug value and creating an efficient marketplace, the industry has fueled a flawed model […]

Stay current with National Alliance

Get updates on health policy, delivery and payment reform, and whole person health trends sent directly to your inbox.